Big Data Trends Across Medical Affairs Functions
Saturday, June 6, 2015 - 07:00
in Mathematics & Economics
In recent years, the biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights. Despite this, the inherent costs and challenges that come with utilizing Big Data have caused the biopharmaceutical sector to embrace Big Data analytics much slower than other industries. According to a recent study by benchmarking firm, Best Practices, LLC, 53% of participants already have a Big Data team or function in place; however, these organizations are still in the early stages of utilizing large data sets from different sources to inform critical aspects of Medical Affairs operations. read more